Xcout Intel
Violet Therapeutics, Inc.
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Subscribe to see Violet Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Violet Therapeutics, Inc. at a glance
Violet Therapeutics, Inc. is a company headquartered in United States. Its most recent funding round raised $7.4M in April 2023. Xcout tracks 10 named people at Violet Therapeutics, Inc., including Darby Schmidt (Chief Science Officer).
Violet Therapeutics, Inc. leadership
- Darby SchmidtChief Science Officer
- Francisco QuintanaAdvisor & Founder
- Kevin HodgettsFounder
- Dilip KodiraVP of Platform & Analytics
- Evan LeboisSenior Director & Head of Biology
- Atsushi UsamiDirector
4 more named people on record for Violet Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Violet Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7.4M | — | |
| Seed | $10.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Violet Therapeutics, Inc. competitors
A few of Violet Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Vibrant Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with operations in China. Founded in July 2019, the firm focuses on revolutionizing protein drug discovery and developing next-generation prodrugs with precise targeting.
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
DeepBiome Therapeutics, Inc. is a venture-backed startup company headquartered in Cambridge, Massachusetts, focused on therapeutics.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Get Violet Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Violet Therapeutics, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access